Finding true north is important for accurate navigation to embarking on the right path. While there may be many paths to making policy decisions, the ultimate goal is to end up with a decision that has been well-informed by evidence. Evidenced-based policy decisions result in more transparent and effective outcomes that are defendable to the public. A case in point is the expansion of antiretroviral treatment (ART) for HIV/AIDS in Thailand. Continue reading
At the 67th World Health Assembly in Geneva in May 2014, a resolution was adopted on Health intervention and technology assessment in support of universal health coverage. Prof David Haslam, Chair of NICE, representing the UK Mission Geneva, addressed the Assembly during a panel session on the role of priority-setting in universal health coverage, alongside counterparts from Thailand, Iran, Ethiopia and the World Health Organisation. The resolution called on Member States to develop and strengthen national and regional capacities for priority-setting, and for the WHO to support these efforts. WHO Director General, Dr Margaret Chan, attended the session and made supportive remarks about the work of NICE, which was named as a “resource organisation” for health technology assessment. Continue reading
iDSI aims to help policymakers in low and middle income countries in building capacity for active priority-setting, such that they can spend limited health budgets in a more efficient and equitable way, and achieve sustainable universal health coverage (UHC). In order to help achieve iDSI this aim, we at NICE International have developed a questionnaire to assess countries’ ‘priority-setting readiness’. We believe this is the first published questionnaire that comprehensively captures priority-setting readiness at a health systems level, beyond the technical dimension of health technology assessment (HTA).
We are now making this questionnaire freely available as a global public good, and we hope it will be useful to policymakers, global health funders, academics and international development partners.
Our questionnaire builds on an earlier questionnaire developed jointly with HITAP for the purposes of a training workshop in Hanoi, Vietnam (Situation analysis of HTA Introduction at national level, version 2.0, October 2013; for non-commercial use only).
As part of a series of events coinciding with the launch of the Gates Reference Case, Tommy Wilkinson (Adviser for Health Economics, NICE International) will be speaking on Tuesday 17 June 2014 at a lunch seminar hosted by the Center for Global Development, Washington DC. If you missed our launch event in London or are attending the HTAi conference, here’s your chance to find out why the Gates RC is important for global health funders, policymakers and researchers alike; and how it will help improve the quality of economic evaluations to ensure that limited resources in health are invested in the best possible way. All are welcome to join the discussion on Twitter using #GatesRC hashtag!
Location, Date & Time
Cost-effectiveness studies compare the costs and benefits of different interventions with the aim of improving decisions on the allocation of scarce resources for health. Or, put simply, they allow policy-makers to set priorities for health spending and consider how the next dollar available can get more health for the money. Continue reading
Universal health coverage (UHC) is now firmly on the global health agenda, and carries with it the ambitious goal of providing “access to key promotive, preventive, curative and rehabilitative health interventions for all at an affordable cost.” So where do we start? A critical first step to delivering on the aspirations of UHC is deciding which services and policies to prioritize and make available. While resources for health care are growing, they are not infinite and hard choices must be made. Continue reading